已收盤 04-02 16:00:00 美东时间
-0.670
-1.84%
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务,助力上市公司传播ESG理念,提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:33
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
Trimas (TRS) has disclosed a new risk, in the Corporate Activity and Growth cat...
03-03 14:02
BWS Financial analyst Hamed Khorsand maintains TriMas (NASDAQ:TRS) with a Buy and maintains $45 price target.
03-03 04:56
TriMas (TRS) announced on Thursday that its board of directors has increased the company’s common stock share repurchase authorization to a total of up to $150 million, adding to the $48.9 million rem...
02-26 21:36
TriMas (NASDAQ:TRS) sees FY2026 sales of $1.073 billion-$1.104 billion vs $657.922 million analyst estimate.
02-26 21:08
TriMas (NASDAQ:TRS) announced its Q4 earnings on Thursday, February 26, 2026 at...
02-26 21:04
TriMas (NASDAQ:TRS) reported quarterly earnings of $0.40 per share which beat the analyst consensus estimate of $0.00 by 19900 percent. This is a 6.98 percent decrease over earnings of $0.43 per share from the same
02-26 21:02
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
TriMas Corporation veröffentlicht Aktualisierung ihres Finanzkalenders TriMas Corporation wird am 26. Februar 2026 um 8 Uhr (Eastern Time) die Ergebnisse für das vierte Quartal und das Gesamtjahr 2025 veröffentlichen. Die Veröffentlichung erfolgt im Bereich „Investors“ auf der Unternehmenswebsite un
02-02 23:00